M

Magle Chemoswed Holding AB
STO:MAGLE

Watchlist Manager
Magle Chemoswed Holding AB
STO:MAGLE
Watchlist
Price: 34 SEK
Market Cap: 667.4m SEK
Have any thoughts about
Magle Chemoswed Holding AB?
Write Note

Magle Chemoswed Holding AB
Investor Relations

Magle Chemoswed Holding AB engages in the provision of contract development and manufacturing services to the pharmaceutical and medical device industry. The company is headquartered in Malmo, Skane. The company went IPO on 2020-06-30. The firm's operations are mainly conducted through the subsidiaries Magle Chemoswed AB and Adroit Science AB. The business is focused on process development and manufacturing of Active Pharmaceutical Ingredients (API) as well as research, development and manufacturing of products in the areas of wound care and diagnostics with particular focus on products based on degradables starch microspheres. Magle Chemoswed also functions as a consultancy in material characterization and solid phase analysis with a main focus on pharmaceutical companies.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Hans Henrik Lidgard
Founder & Chairman
No Bio Available
Mr. Justin Pierce
Chief Executive Officer
No Bio Available
Ms. Petra Jonsson Sjolin
Chief Financial Officer
No Bio Available
Mr. Fredrik Andersson
Chief Operations Officer
No Bio Available
Ms. Megi Medzmariashvili
Legal Counsel
No Bio Available
Ms. Helena Ossmer Thedius
Chief Marketing & Innovation Officer
No Bio Available
Mr. Simon Jegou
Chief Strategy Officer
No Bio Available

Contacts

Address
SKANE
Malmo
Agneslundsvagen 27
Contacts
+46703478617